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All mature B cells coexpress major histocompatibility complex (MHC) class II molecules, I-A 
and I-E,  which are restriction  elements required for antigen presentation  to CD4 + T  cells. 
However, the expression of class II during the early stages orB cell development has been unclear. 
We demonstrate here that there is a difference in the expression of class  II during murine B 
cell development in the fetal liver and adult bone marrow (BM). These differences define two 
distinct B cell developmental pathways. The Fetal-type (FT) pathway is characterized by pre-B 
and immature IgM + B cells generated in the fetal liver which initially lack all class II expression. 
In contrast, the Adult-type (AT) pathway is typified by B cells developing in the adult BM which 
express class II molecules from the pre-B cell stage. In vitro stromal cell cultures of sorted fetal 
liver and adult BM pro-B cells indicated that  the difference in I-A expression during B  cell 
development is intrinsic to the progenitors. In addition, we show that FT B cell development 
is not restricted to the fetal liver but occurs in the peritoneal cavities,  spleens, liver, and BM 
of young mice up to at least 1 mo of age. The AT B cell development begins to emerge after 
birth but is, however, restricted to the BM environment. These findings indicate that there are 
two distinct B cell developmental pathways during ontogeny, each of which could contribute 
differentially to the immune repertoire and thus the functions of B cell subsets and lineages. 
B  cell lymphopoiesis is first seen in the fetal liver and even- 
tually shifts to the bone marrow (BM) 1 in the adult (1). 
In these sites, B cell development occurs in sequential stages, 
starting from pro-B and differentiating into pre-B and B cells 
(2). Cells at different stages of maturation can be defined by 
their cell surface phenotypes, differential gene expressions, 
and status of Ig gene rearrangements (3). For example, pro-B 
cells are B22(Y~  hi, express the recombination activating 
genes, RAG-1 and RAG-2, and undergo D-J rearrangement 
at the Ig H  chain genes loci. Pre-B cells are B220 int CD43 l~ 
and have cytoplasmic/z proteins, and finally,  B calls express 
cell surface Ig (slgM) and downregulate both the RAG genes 
expressions (2-4). 
There are known differences between fetal liver and adult 
BM B lymphopoiesis. It has been shown that the enzyme 
terminal  deoxynucleotidyl  transferase  (TdT)  (5)  and  the 
precursor lymphocyte-regulated myosin-like L chain (PLRLC) 
(6)  are expressed in pro-B cells in the BM but  not in the 
fetal liver (4).  The lack of TdT expression results in a lack 
of N region additions in the fetal mouse Ig V-D-J junctional 
1 Abbreviations used in this  paper: APC, allophycocyanin; AT, adult type; 
bi, biotin; BM, bone marrow; FI, fluorescein; FT, fetal type; PerC, peritoneal 
cavity. 
sequences as compared with those derived from the adult BM 
(7, 8). More significantly, recent studies (9,  10) show that 
fetal liver but not adult BM pro-B cells readily reconstitute 
CD5 + B cells,  strongly suggesting that there are intrinsic 
developmental differences in the B cell progenitors obtained 
at distinct time points during ontogeny. However, to date, 
no phenotypic cell surface markers have been identified which 
can distinguish between fetal liver and adult BM-derived pro- 
genitor cells. Similarly, no phenotypic differences have been 
observed in the pro- or pre-B cells derived from fetal or adult 
B cell progenitors. The lack of such distinction complicates 
a detailed analysis  of the role each developmental pathway 
plays in the derivation and functions of B cell subsets and 
lineages and their contributions to the immune repertoire. 
In addition, it is not known when a developmental switch 
occurs between the fetal and the adult B cell differentiation 
pathways and to what  extent  they overlap in ontogenetic 
timings. 
All mature B cells constitutively express MHC class II mol- 
ecules on their cell surfaces (11, 12).  The class II molecules 
are heterodimeric glycoproteins (13) consisting of an ot and 
chain which are encoded within the I-A and I-E subregions 
of the MHC  (11). Appropriate expression of these class  II 
molecules is required for proper presentation of peptide an- 
507  J. Exp.  Med. ￿9  The Rockefeller  University Press ￿9 0022-1007/94/08/0507/10 $2.00 
Volume  180  August 1994  507-516 tigens to recognition by CD4 + T cells (14). To date, studies 
indicate that the expression of the class II genes is coordinate 
(12,  15,  16). 
Early studies on the timing of class II expression during 
B cell development have yielded contradictory results. Studies 
by Lala et al. (15) and Mond et al. (16) indicated that B cells 
acquire class II and slgM concurrently during development. 
On the other hand, Kearney et al. (17) using immunofluores- 
cence microscopy showed that  there  was  a population  of 
slgM + cells in neonatal spleens  that lack class II expression. 
Hammerling  et al.  (18)  also reported  the presence of class 
II-  slgM § cells  and  suggested that  they are newly gener- 
ated B ceils. Using long-term BM cultures that presumably 
mimic ,~ormal B cell development in vivo, Dasch and Jones 
(19) also suggested that slgM § ceils that lack class II mole- 
cules on their cell surfaces were immature B cells. These ear- 
lier works contrasted with recent studies by Miki et al. (20) 
which provided evidence that class II molecules may be ex- 
pressed at the pre-B cell stage.  This group showed that BM 
pre-B cells treated with anti-class II mAb or obtained from 
mice transgenic for an antisense I-A construct have dimin- 
ished B cell development in vitro. These studies, however did 
not demonstrate directly the stage of B cell development at 
which I-A is first expressed. Recently, Tarlinton (21) showed, 
by flow cytometry, that class II molecules were expressed at 
the pre-B cell stage during B cell development in the BM. 
However, the report still did not resolve the differences reported 
earlier  on the presence of class II- IgM + ceils. All the above 
studies of class II expression have assumed that B cells follow 
the same developmental pathway throughout ontogeny. Given 
the known differences between fetal liver and adult BM B 
cells and that slgM + cells lacking class II had been reported 
in neonatal spleens (17, 18), we compared class II expression 
during  fetal  liver and adult  BM B lymphopoiesis. 
We find that there is a difference in class II expression during 
B cell development in  the fetal  liver and BM.  In the fetal 
liver, pre-B cells and newly generated slgM § cells do not ex- 
press any class II molecules, I-A or I-E. In contrast, class II 
molecules are found to be expressed on pre-B cells in the adult 
BM.  Using  I-A  expression  on  pre-B  cells  and  immature 
slgM + cells as a distinguishing  marker between adult BM 
and fetal liver B cell developmental pathways, we further show 
that Fetal-type (FT) B cell developmental pathway occurs in 
many neonatal lymphoid organs. In contrast, the Adult-type 
(AT) B cell developmental pathway is largely confined to the 
BM environment.  Our results suggest the presence of two 
distinct B cell developmental pathways during ontogeny. This 
finding has great implications for the generation of the im- 
mune repertoire and also to the derivation of B cell lineages 
and subsets. 
Materials and Methods 
Animals.  BALB/c,  BAB/25, C57BL/6, and CBA/Ca mice were 
obtained from our animal facility. All adult mice studied were 2-3- 
mo-old.  For timed pregnancies, females were housed in separate 
cages from the males until mating.  The appearance of a vaginal 
plug after overnight mating was labeled as day 1 of gestation. Age 
of neonates was given with respect to the day of birth. 
Antibodies.  The  following  rat  anti-mouse  mAbs:  anti-IgM 
(331.12), anti-B220 (ILA3-6B2), and anti-CD43 ($7) were produced 
and conjugated  to biotin (bi) or fluorochromes (fluorescein [F1]) 
as described (I0, 22, 23). The mouse mAbs: anti-I-A  J (AMS 32.1), 
anti-I-E  (14-4-4s), anti-I-A b (AF6-120.1), anti-I-A  k (11-5.2), and 
anti-H-2K a (SFI-I.1) were obtained from PharMingen (San Diego, 
CA). 
Cell Pre1~rations.  Single  cell suspensions of BM were prepared 
by injecting staining medium  (deficient RPMI [Irvine Scientific, 
Santa Ana, CA] containing  10 mM Hepes, 3% FCS, and 0.1% 
NAN3) into femurs and tibia using a 1-ml syringe and 26-gauge 
needle. Peritoneal cells were obtained by injecting staining medium 
into the peritoneal cavities (PerCs) of neonates and extracting with 
Pasteur pipettes. Fetal liver and spleen cells were prepared by dis- 
sociation between frosted glass slides. All ceils were treated with 
R.BC lysing solution (0.15 M NH~C1, 1.0 mM KHCO3, and 0.1 
mM Na2 EDTA) to eliminate erythrocytes and resuspended at 2.5 
x  107 cells/ml in staining medium  (24). 
Stainin$ Flow Cytometry, and Cell Sorting.  Cells were incubated 
on ice with optimal amounts  of F1, PE, allophycocyanin [APC]- 
conjugated or biotin (bi)-conjugated Abs for 15 min and washed 
three times with staining medium. Bi-conjugated Abs were revealed 
with Texas red-avidin. Flow cytometric  analyses and cell sorting 
were conducted using a modified dual laser/dye laser FACStar  P~us| 
(Becton Dickinson  & Co.,  San Jose, CA) equipped with appro- 
priate filters for seven parameter analyses. Samples were kept on 
ice during  sorting.  ILeanalysis of sorted populations consistently 
showed purity in excess of 95%.  Analyses of cell samples always 
included propidium iodide (1/~g/ml) for dead cell exclusion. Data 
were analyzed using FACS/DESK (Stanford University, Stanford, 
CA) and unless otherwise noted, are presented as 5% probability 
contour plots. 
Culture Conditions.  BM stromal layers were established (25) by 
seeding 3  x  10  s BAB/25 BM cells per well of a 24-well tissue cul- 
ture plate 3 wk before the initiation of cultures. The cultures were 
fed twice weekly in culture medium  (RPMI-1640 supplemented 
with 5  x  10 -s M 2-ME, 5% FCS, and penicillin/streptomycin) 
and kept in a humidified 5% CO2 incubator at 37~  Only wells 
with no nonadherent cells were used in the experiments. The FLST2 
stromal cell line used was also maintained in standard medium and 
passaged by treatment  with trypsin-EDTA (26). All experimental 
cultures with stromal layer were performed in 24-well plates with 
I ml culture medium. Typically, sorted cells were seeded at 30,000 
cells/well on the stromal layer and cultured  for 4 d. The cultures 
were fed every other day by aspirating off half the medium and 
refeeding with an equal volume of fresh medium.  In certain sets 
of experiments, supernatant from Con A-stimulated splenic T cells 
was added to 10% of the volume at the time of initiation  of cul- 
tures. After cultures, cells were recovered and stained for B220, 
IgM, I-A, and I-E expression. 
Results 
Class II Expressions on BM B  Cell Populations.  B lineage 
cells in the adult BM can be resolved into different stages 
of maturation based on their differential expression of B220 
and CD43 (lenkosialin)  (3). In Fig. 1 A, flow cytometric anal- 
ysis of an adult BALB/c BM identifies three populations: pro-B 
ceils (B2201~ CD43hi); pre-B and immature  B cells (B220  int 
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Figure  1.  I-A is expressed  on pre-B and immature sIgM § cells in adult 
BALB/c BM. BM cells from a 2.5-mo-old BALB/c mouse were stained 
with ^manti-B220/6B2, Flanti-lgM, PEanti-CD43, and bianti-I-Ad (AMS 
32.1) or bianti-I-E (14-4-4s). (.4) The boxed areas delineate the different 
stages of B cell maturation resolved by B220 and CD43/S7 phenotypes 
as defined by Hardy et al. (3). Pro-B  cells are B220  lo CD43 hi, pre-B/im- 
mature B cells are B220  int CD43 l~ and mature B cells are B220biCD43- 
and represented 6, 23, and 3% of the total 8M cells, respectively.  The 
use of a brighter PEanti-CD43 reagent reveals a low level of CD43 ex- 
pression on pre-B and immature B cells not seen in previous reports (3). 
(B) Shown are the IgM, and class II, I-A and I-E expressions of the gated 
popuhtions. The horizontal lines designate the cutoff for positive  and nega- 
tive cells. Data shown are representative of numerous separate analyses 
(, >10). 
CD431~  and  mature  B  cells  (B220  hi  CD43-).  Mature  B 
cells are further distinguished from immature B cells by their 
higher expression level of IgD and CD23 (data not shown). 
Fig.  1 B  shows the expression of IgM, I-A and I-E for each 
of these populations. Pro-B cells (left) do not express any sIgM 
nor class II antigens on their cell surfaces. The class II mole- 
cule, I-A is first expressed on pre-B cells (middle). In 3 mo 
adult BM,  "~30% of the pre-B cells are I-A-  and 70%  are 
I-A +. Thus the expression of I-A subdivides the pre-B cell 
compartment.  All sIgM + B cells in the BM express I-A on 
their cell surfaces.  As  seen in  the middle and  right  panels 
of Fig.  1, immature B cells express a lower level of I-A (in- 
tensity =  7) compared with mature B cells (intensity =  20). 
These observations confirm recent data by Tarlinton (21) which 
showed that class II is first expressed during the pre-B cell 
stage  in  the BM. 
The I-A-  pre-B cells in the adult  BM represent an ear- 
lier stage of maturation than the I-A + pre-B. When sorted 
I-A-  pre-B cells were cultured for 2 d,  only 10%  of the B 
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Figure 2.  Fetal  liver-derived pre-B and immature slgM + B cells ini- 
tially do not express  class II antigens. Fetal liver  cells from a day 19 BALB/c 
fetus were stained as described in Fig. 1. (i~p) Contour plot of B220 vs. 
CD43 expression. (Bottom) Class II expression on pre-B and immature 
IgM + B cells (B220  +  , CD43d"]l; gated population). (Boxed  area) Approx- 
imately 33% of the total cells in the day 19 fetal liver. Data shown were 
representative of several (n  =  5) independent analyses in BALB/c mice 
and were reproducible in various other strains. 
cells in culture remained as I-A-  pre-B and  ",~67 and 23% 
became  I-A +  pre-B  and  I-A +  IgM +  B  cells,  respectively 
(data  not  shown).  Similar  culturing  of I-A +  pre-B  cells 
yielded only I-A §  pre-B and  I-A +  IgM +  B  cells,  (44 and 
56%, respectively). Thus the data supported a sequential order 
of maturation  of pre-B cells from  a  I-A-  to a  I-A §  stage 
and finally to I-A +  IgM + B  cells. 
The Tarlinton study used a rat anti-mouse class II Ab that 
could not distinguish between I-A or I-E. Using individual 
anti-I-A mAbs, we found similar patterns of I-A expression 
on adult BM B cells from CBA/Ca and C57BL/6 mice (data 
not shown). However, we now report differences in cell sur- 
face expression  of I-E  during  BM  B  cell  development  in 
different mice strains.  In BALB/c mice, I-E is not detected 
on the cell surface of pre-B or newly generated immature 
B cells, but rather is first expressed on mature B cells (Fig. 
1 B).  In contrast,  in the adult BM of CBA/Ca  mice,  I-E, 
like I-A, is first expressed on pre-B cells (data not shown). 
The reason for this difference in I-E expression between the 
two strains of mice is not known. The anti-I-E Ab used was 
made against  EoL of the k  haplotype but cross-reacts with 
Eo~ of the d, p, and r haplotypes (27). It is unlikely that the 
difference in I-E staining on BM pre-B and immature B cells 
is due to the preferential staining of one haplotype with the 
anti-I-E Ab since the Ab detects equivalent levels of I-E an- 
tigens  on  splenic  IgM +  B  cells  in  BALB/c  and  CBA/Ca 
mice (data  not  shown). 
Fetal Liver Pre-B and Immature B Cells Do Not Express Class 
II Molecules.  In the fetal liver, B cell maturation occurs in 
a single wave (28) with pro-B cells emerging at day  14 of 
509  Lain and Stall gestation, and slgM + B cells first detectable at day 18 or 19 
of gestation. Fig. 2 shows a flow cytometric profile of a day 
19 fetal liver stained with anti-B220, anti-CD43, anti-IgM, 
and anti-I-A or anti-I-E. Unlike the profiles in the adult BM, 
distinct populations of B cells in various stages of matura- 
tion are not well resolved in the fetal liver. However, most 
of the B220 + cells at this time point are stromal indepen- 
dent for growth (28) and are thus beyond the pro-B cell stage 
of differentiation.  Cells  within  the  gated B220 +  CD43 § 
fraction are lymphoid in morphology and in addition, more 
than 80%  of the sorted B220 + Ig-  cells  stained for cyto- 
plasmic #  (data not shown) and are thus pre-B cells. 
With respect to class II, a totally different pattern of ex- 
pression  is  seen during  fetal B  lymphopoiesis.  Both  Ig- 
pre-B and Ig + immature B cells do not express I-A or I-E 
(Fig.  2). This is in striking contrast to the situation in the 
adult BM where I-A can be detected on the cell surface of 
pre-B and immature B cells (Fig.  1). This lack of class II ex- 
pression during fetal liver B lymphopoiesis is not strain de- 
pendent since it is also seen on C57BL/6 and CBA/Ca mice 
(data not shown). 
The Difference  in I-A Expression during Fetal  Liver and Adult 
BM B Lymphopoiesis  Is Intrinsic to the B Cell Progenitors.  There 
are several possibilities  that could explain the lack of I-A ex- 
pression during B cell development in the fetal liver: (a) Differ- 
ences  in  the  fetal  and  adult  stromal  microenvironment 
influences class II expression on developing B cells;  (b) the 
presence of T  calls or their factors are required for class II 
expression; and/or (c) the difference is due to the intrinsic 
properties of progenitor cells derived at distinct ontogenetic 
timings. 
To address these possibilities,  pro-B cells were sorted from 
either 3-mo-old BALB/c BM or day 16 BALB/c fetal liver 
(Fig. 3) and cultured for 4 d on the FLST2 fetal liver-derived 
stromal line (26),  which has been shown to support B call 
differentiation from very early stages of development (3). The 
pro-B cells found in the adult BM and day 16 fetal liver are 
at an equivalent stage of differentiation since most of these 
cells are undergoing D-J rearrangement and are also depen- 
dent on stromal contact for growth and differentiation (3, 9). 
The BM pro-B  cells  gave rise to both I-A + pre-B and 
I-A + IgM + B cells in culture. These calls were I-E-  (data 
not shown). In contrast, the fetal liver pro-B cells gave rise 
to both pre-B and slgM + ceils that were I-A-  and I-E-. 
This does not appear to be a simple difference in the timing 
of I-A expression since after 8 d of culture there were still 
no I-A + pre-B or immature B cells in the fetal liver pro-B 
cultures (data not shown). Similar culturing of fetal liver and 
BM pro-B cells on heterogeneous BM stromal cells yielded 
identical differences (data not shown). Thus, the differences 
in B cell development observed in our in vivo analyses (Figs. 
1 and 2) are completdy reproduced in in vitro cultures. The 
data indicate that the stromal microenvironment is not respon- 
sible for the differences in class II expression during B call 
development at these two stages of ontogeny. 
It is unlikely that the lack of class II expression on fetal 
pre-B/immature B ceUs is due to a lack of T  cell factors or 
help. Culturing of day 16 fetal liver pro-B cells with super- 
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Figure  3.  The difference  in class II expression on pre-B and newly gener- 
ated IgM + B cells is intrinsic to the developmental program of pro-B calls 
derived at distinct  ontogenetic timings.  Cells from BALB/c day 16 fetal 
liver and 3-too-old  adult  BM were stained as in Fig.  1 except that both 
bianti-I-A and bianti-I-E were used simultaneously. Pro-B ceUs were sorted 
as B2201~ CD43  hi, IgM-, and class II (I-A and I-E)- and cultured  for 
4 d on the FLST2 stromal ceUs. Typically, 30-50,000  cells were cuhured 
in a single well. The relative cell recoveries after a 4-d culture were 2-2.5 
times the input cell numbers for both BM and fetal liver pro-B cells. Cells 
recovered from the cultures were stained with ApCanti-B220, Flanti-IgM, 
P%nti-I-A, and bianti-I-E. The cells presented in the IgM vs. I-A contour 
plots were pregated for B220 + calls in order to eliminate contaminating 
stromal cells. Approximately 13 and 18% of the B220 + cells in the fetal 
liver and BM cultures were IgM +, respectively, and of the B220 + IgM- 
cells in the adult BM cultures, 62% were I-3, + and 38% were I-A-. Data 
shown were representative of individual five adult BM and three fetal liver 
pro-B  cultures. 
natants from the EL4 T cell line or Con A activated splenic 
T cells did not yield any I-A + B cells (data not shown). Fur- 
thermore, class II- pre-B cells and immature IgM + B cells 
are found in the spleens of mice up to 5-6 wk of age when 
the level of splenic T cells have reached the adult equivalent. 
These data strongly suggest that the differences in class II 
expression during B cell development are intrinsic to the B 
cell progenitors present in the fetal liver and adult BM. This 
difference would allow us to distinguish between FT and AT 
B cell developmental pathways. 
FT B Cell Developmental  Pathway Occurs in Many Neonatal 
Lymphoid Organs and Extends to Adulthoo~  Analyses of spleen 
ceils from mice at various time points after birth revealed 
the presence of a population of B220 + IgM-  cells (Fig.  4 
A, population a). Histologic studies indicated that these are 
pre-B cells as "~75-80% of these B220 + IgM-  cells stained 
positive for cytoplasmic/z (data not shown). These pre-B cells 
did not express I-A or I-E. As seen in Fig. 4 and summarized 
in Table 1, I-A-  pre-B cells can be detected up to 1 mo of 
age in murine spleens, well beyond the stage of fetal ontogeny. 
During the first month the spleen increased more than 200- 
fold in cellularity from 0.4 to 88  x  106 cells. Although the 
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Figure  4.  Presence  of I-A-  pre-B cells in 
murine  spleens  during  neonatal  ontogeny. 
Spleen cells were obtained from BALB/c mice 
at the ages indicated and stained with mCanti- 
B220,  bianti-IgM,  PEanti-I-A, and Flanti-I-E. 
(A) The contour plots show the expression of 
IgM vs.  I-A  or  I-E on B  lineage (gated for 
B220 +) cells. Cells in population a are IgM- 
pre-B cells. Population b cells are IgM + I-A 
or I-E negative. Cells in population c coexpress 
IgM and I-A or I-E. (/3) Correlation of I-A and 
I-E on IgM + B cells. Spleen cells were gated 
on B220 and IgM (cutoff, 4 in A). Three popu- 
lations are gated:  (d) Class II- ; (e) I-A  l~ I-E- ; 
and (~ I-A and I-E double positive. 
percentage  of I-A-  pre-B cells (calculated as  %B220 +  - 
%B220 + IgM + from Table 1) decreased, the absolute num- 
bers actually increased during this period (from 0.04  x  106 
cells at day 1 to 5.3  x  106 cells at 1 mo) and then decrease 
such that at 3 mo the levels were equivalent to background. 
To confirm that these splenic I-A- pre-B cells were in the 
FT developmental pathway, splenic B220 + IgM-  I-A-  cells 
were sorted from day I  to day 12 neonatal spleens, cultured 
on the FLST2 stromal line,  and analyzed 4 d later for the 
expression  of I-A  on B  cells  arising  in  the cultures.  The 
I-A- pre-B cells gave rise to immature slgM + cells that did 
not express any class  II antigens  (data not  shown). 
1 d after birth, 78% of the splenic IgM + B cells are I-A- 
and I-E-  (Table 1 and Fig. 4 B, population d). This confirms 
Table  1.  B Cell Development in the Spleen of Young Animals 
Total  No.  of 
spleen cells 
Age  N*  x 106  B220 § 
Percentage  of total cells*  Percentage of B220 § IgM +  s 
B220 + IgM +  I-A- I-E -  I-AI~  -  I-A § I-E + 
%  % 
1  d  6  0.4  14  2.5  78  11  11 
_+  0.1  _+  0.9  _+  1.0  _  5.6  _+  3.5  __  5.3 
4  d  3  6.7  28  17  41  16  43 
_+  1.8  +_  9.1  _+  6.3  _  20  _+  7.2  _+  18 
10 d  5  25  38  21  15  16  69 
__  9.0  _  5.2  __  5.1  +_  2.2  _+  3.4  _  1.8 
1  mo  5  88  44  38  6  8  86 
_+  10  _+  2.1  _+  1.9  _+  1.5  _+  2.3  __  2.5 
3  mo  3  95  43  42  0.3  0.9  99 
_+  14  +_  1.0  _+  1.1  _+  0.2  _+  1.0  _+  1.3 
* Number of animals tested. 
* Values are based on gates shown in Fig. 6. The percentage of B220+IgM + cells was calculated  as the number of cells in populations b  and c di- 
vided by the total number of spleen  cells.  The percentage of pre-B cells can be determined from  %B220 +  -  %B220§ 
S Values are determined from the gated populations shown in Fig. 6: I-A-I-E-, population d; I-AIoI-E-, population e; I-A+I-E+, population f and 
are expressed  as the percentage of B220+IgM + cells. 
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Figure  5.  The PerC is a site ofB lymphopoiesis in neo- 
natal mice. PerC calls obtained from BALB/c mice have 
been gated for lymphocytes by forward and side scatter. 
(A) (Left)  IgM vs. B220 expression.  The gates identify 
the pre-B and IgM + B cell populations. (Right)  Class II 
expression on the B220 + (cutoff >4) cells. The gates de- 
note the class II- pre-B cells. (B) IgM vs. B220 contour 
plots of peritoneal cells from mice of different ages.  The 
average number of cells recovered are:  10 d, (5.8  +  1.2) 
x  10  s(n  =  5); 16d,(1.3  _+  0.3  x  106(n  =  2);lmo 
(1.5  _+  0.5)  x  106(n  =  2); and3mo(6.3  _+  1.3)  x 
106 (n  =  3).  The frequency of B cells (and pre-B) as a 
percentage of total cells shown in the plots is: 10 d, 7.5% 
(2.2%);  16 d, 31.1% (1.9%);  1 mo, 22.2%  (0.2%),  and 
3  too, 64%  (0.1%). 
early data by Kearney et al. (17) which showed the presence 
of B cells that lacked class II expression in neonatal mice. 
As with the I-A- pre-B cells,  these I-A-  IgM + immature 
B cells can be detected out to  1 mo of age and are absent 
in 3-mo-old mice. In 1-d-old mice, a small population of the 
IgM + B cells appears to express very low levels of I-A in the 
absence of I-E (Fig. 4 B, population e), again suggesting that 
in BALB/c mice, I-A may be expressed briefly before I-E. 
At this time there is no distinct population of I-A §  I-E + 
IgM B cells (Fig. 4 B, population J). In the first week after 
birth there was a major increase in the number of splenic 
IgM + B cells expressing both class II antigens, and by 3 mo 
of age, essentially all splenic B220 + cells coexpress IgM, I-A, 
and I-E. 
I-A-  pre-B ceUs were also present in the neonatal livers 
up to at least the second week of birth (the last point we 
were able to readily isolate lymphocytes from this organ). 
Like the pre-B cells found in the neonatal spleens, the I-A- 
pre-B cells stained for cytoplasmic #  and gave rise to class 
II-  IgM §  cells  in  the FLST2  stromal cell  cultures,  indi- 
cating that they originate from the FT progenitor cells (data 
not shown). 
Similar flow cytometric analyses of the PC cells from young 
mice also revealed the presence of I-A- pre-B cells (Fig.  5). 
At 10 d of age (the earliest time point tested) "~40% of the 
total B lineage cells were B220 + IgM- pre-B cells that were 
positive for cytoplasmic #. Like the pre-B cells found in the 
spleens and livers, most of these cells do not express any de- 
A  4 days  8 days  16 days  1 month  3 months 
I-A ,o: 
,,o,oo  ,,o,oo  ,,o,oo   ,o,oo  ,,o,oo 
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8o- 
5o~ 
50. 
40' 
30- 
20' 
lO-.: 
o  ~ 
B  16 days 
h 
i 
d  [] %.-.,.." 
a 
m %,-A+m.u-EAT)  (;;~-) 
average percentages of pre-B and slgM + cells  found in the BM are respectively: 4 d,  27.2%,  4.6%;  8 
30.4%,  10.5%;  3  mo,  20.9%,  8.1%. 
Figure  6.  Developmental switch from FT 
to AT B cell differentiation pathway occurs in 
the young BM. BM cells were obtained from 
BALB/c mice at the ages indicated and stained 
as in Fig. 1. (A) Contour plots of IgM vs. I-A 
expression is shown for pre-B/immature B cells 
(B220  int CD431o),  gated  as in  Fig.  1.  These 
cells  are  divided  into  four  populations:  (a) 
I-A + IgM- pre-B cells; (b) I-A + IgM + imma- 
ture B  cells;  (c)  I-A-  IgM-  pre-B cells;  (d) 
I-A-  IgM +  immature  B  cells.  (B)  Graph 
showing the switch from FT to AT B cell de- 
velopmental pathways in the BM over age. The 
values plotted are the percentage of IgM + im- 
mature B cells that are I-A -  (FT) and the per- 
centage  of IgM-  pre-B  cells  that  are  I-A + 
(AT). These values are calculated as shown in 
B based upon  the populations  defined in A. 
The number of cells recovered from femur and 
tibia of one hind limb of mice of different ages 
are: 4 d, (1.1  _+ 0.1)  x  106 (n  =  4);  8  d,  (4.6 
-+ 0.9)  ￿  10 6  (n  =  3); 16 d, (1.1  _+  0.2)  x 
107 (n  =  3);  1 mo (2.2  -+  0.3)  x  107 (n  = 
2); and 3 mo, (2.7  _+ 0.1)  x  107 (n  =  3). The 
d,  23.6%,  4.5%;  16 d, 31.9%,  9.5%;  1 mo, 
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Figure 7.  Young BM pro B cells contain a mixture of precursor  cells 
that differentiates  along both FT and AT developmental  pathways.  (A) 
BM from BALB/c mice of different ages were stained as in Fig. 1 A. Pro-B 
cells (cells in gates) were sorted and cultured on FLST2 stromal cells. (B) 
After 4 d of culture,  cells were recovered and stained as in Fig. 3. The 
relative cells recoveries were similar to those in Fig. 3. The cells presented 
in the IgM vs. I-A contour plots were pregated  for B220 + cells. Percen- 
tages of total cells for each population are shown in the figures. The data 
are representative of three independent  sets of culturing experiments,  each 
with multiple mice of different  ages. 
tectable levels of cell surface class II antigens (Fig. 5 A). These 
pre-B cells were readily detected up to 2.5 wk of age in this 
location (Fig. 5 B). When these peritoneal pre-B cells were 
sorted and cultured for 4 d,  they generate IgM + cells at a 
frequency ('-20%  of B220 + cells in culture) comparable to 
the pre-B cells derived from neonatal spleens, livers, or adult 
BM.  These IgM + cells were I-A-  (data not shown). 
AT B Cell Developmental  Pathway Begins to Emerge after Birth 
but is Confined to the BM.  In the neonatal liver, spleen, and 
PerC there was little evidence of AT B cell development as 
indicated by the absence of I-A + pre-B cells. Since the BM 
is the site of AT development in the adult, we investigated 
B cell development in BM at various ages (Fig. 6). As in the 
adult BM, pro-B, pre-B, and immature B cells could be dis- 
tinguished by B220 and CD43 staining in the young neo- 
natal BM (Fig.  7 A), indicating that a steady state level of 
B lymphopoiesis is already occurring in this location. 
Fig. 6 A  shows the expression of IgM and I-A on B220 i"t 
CD431~ BM cells  (pre-B and immature B cells)  at various 
time points after birth. In young mice, this population con- 
tained both I-A + and I-A-  pre-B cells (Fig.  6 A, popula- 
tions a  and c, respectively) and I-A + and I-A-  IgM + im- 
mature B cells (Fig. 6 A, populations b and d, respectively), 
suggesting the simultaneous presence of the two distinct B 
cell developmental pathways. Whereas it is difficult to deter- 
mine the exact contribution of each developmental pathway, 
in Fig. 6 B the percentage of total immature B cells (popula- 
tions b  +  d) which are I-A-  (population d) is given as an 
approximation of the FT pathway. This is probably an un- 
derestimate since some of the I-A + immature B cells may 
be FT B cells that have begun to express I-A. Similarly, the 
percentage of total pre-B cells (populations a + c) which are 
I-A +  (population  a)  is  given  as  a  measure  of  the  AT 
pathway. Again, this is an underestimate since AT pre-B cells 
are initially I-A-. The value of 70%  I-A + pre-B cells in a 
3 mo BM probably represents close to  100%  AT develop- 
ment since there is no clear population of I-A-  immature 
B cells at this time point (Fig.  6 A). 
It is clear that the FT B cell developmental pathways is 
the major B cell developmental pathway in the BM at birth 
(Fig. 6 B). In a 4-d-old BM, the vast majority of the IgM + 
immature B cells (82%)  do not express I-A whereas only 
5%  of the pre-B cells present are I-A +.  As the mice age, 
there is an increase in the frequency of I-A § pre-B cells and 
a decrease in the percentage of I-A-  IgM + cells (Fig.  6 B) 
indicating a gradual switch from one pathway to the other, 
with the AT differentiation pathway becoming the predomi- 
nant pathway in older mice. 
The I-A-  IgM § B cells in the BM could be due to FT 
B cells developing in other organs (e.g., liver, spleen, or peri- 
toneal cavity) and migrating into the BM location, or they 
could be generated de novo in the BM together with B cells 
differentiating along the AT B cell developmental pathway. 
To address this possibility,  B2201~ CD43 hi pro-B cell were 
sorted from neonatal mice BM and cultured on the FLST2 
stromal line (Fig.  7). Pro-B cells sorted from a day 4 or day 
10 newborn BM cultured for 4  d  gave rise to both I-A § 
pre-B cells indicative of AT development, as well as I-A- 
IgM §  immature  B  cells  indicative  of FT  development. 
Similar to the in vivo analysis of pre-B and immature B cells 
in the neonatal BM (Fig. 6), pro-B cells derived from older 
mice gave rise to a greater frequency of I-A + pre-B and I-A + 
IgM + B cells. In cultures of 4-6-d-old BM pro-B cells, 60% 
of the IgM + B cells were I-A- whereas in cultures of 2-3- 
mo-old BM pro-B cells, only 20% were I-A-  (Fig.  7). The 
culturing experiments confirm that  the pro-B  population 
present in young BM actually contains a mixture of precursor 
cells derived from both the FT and AT developmental pathways 
and that as the animals age, the dominant population ofpro-B 
cell precursors shifts from FT to AT. Hence, in contrast to 
other neonatal lymphoid organs where FT B cell develop- 
mental pathway predominates, the BM is the only location 
where both the developmental pathways coexist early in on- 
togeny (Fig.  6). 
Discussion 
We demonstrate that there is a basic difference in fetal and 
adult B cell ontogeny with respect to MHC class II antigens, 
considered basic to B lymphocyte function and immunoreg- 
ulation. We have distinguished two distinct B cell develop- 
mental pathways: the AT typified by B cells developing in 
the  adult  BM  which  never express  their  surface antigen 
receptors in the absence of I-A expression, and the FT in 
which developing B cells first expressed their surface Ig in 
the absence of any MHC class II antigens. Furthermore, we 
demonstrate that this difference  in B cell devdopment is likely 
to be intrinsic to progenitor cells arising at distinct ontogenetic 
timings. This difference allows us for the first time to pheno- 
typically distinguish pre-B and immature B cells arising from 
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Figure 8.  Time course for FT and AT B cell 
developmental pathways occurring in various 
organs. See text for description. The intensity 
of each line  is an approximate indication of the 
relative level of B lymphopoiesis in the organ 
at that time. 
progenitor cells of distinct developmental pathways. Finally, 
based upon these distinctions we have shown that FT B lym- 
phopoiesis (at least from the pre-B cell stage) occurs in var- 
ious lymphoid organs and extends to at least  1 mo of age 
whereas AT B lymphopoiesis is restricted to the BM envi- 
ronment. 
In addition to the difference in the expression of class II 
in FT and AT B cell development, we were surprised to find 
that in BALB/c  mice, AT pre-B cells expressed I-A in the 
absence of I-E both in vivo (Fig.  1) and in in vitro cultures 
(Fig. 3). This is in striking contrast to previous studies using 
in vitro transcription systems or macrophage cell lines which 
indicated that the I-A and I-E class II genes were coordinately 
regulated (11,12,29). Yet, in CBA/Ca mice, I-A and I-E were 
coordinately expressed in both the FT and AT developmental 
pathways (data not shown). It is not clear why there is such 
a difference in cell surface expression of I-E on pre-B and im- 
mature B cells in the BM of mice of different genetic back- 
grounds. The difference could be due to epitope or glycosy- 
lation differences during different stages orb cell development. 
For example, at the pre-B cell stage, the E,~ chain may as- 
sociate with  AS  (or another  stage-specific  chain) and the 
anti-I-E  k mAb might be able to recognize this combination 
in CBA/Ca but not BALB/c. Alternatively, it could simply 
reflect differences in the regulation of I-E expression influenced 
by the genetic background of mice. 
Previous studies have demonstrated that there are significant 
differences in B cells developing at the two distinct ontogenetic 
sites, the fetal liver and the adult BM. Notably, TdT (respon- 
sible for N region insertions) (5) and the PLKLC (6) are ex- 
pressed in pro-B cells in the adult BM but not in the fetal 
liver (4). However since there have been no phenotypic markers 
to distinguish the FT and AT B cell development, it has not 
been possible to determine whether or not the FT develop- 
ment is in fact restricted to fetal ontogeny. These studies dearly 
demonstrate that the FT B cell lymphopoiesis occurs in a 
variety of organs and extends well into adulthood. 
Taken together, our data suggest a pattern of B cell differen- 
tiation during ontogeny as shown in Fig. 8. The first major 
B lymphopoietic site is the liver where B lineage cells are 
first detected by day 14-15 of gestation and are generated until 
at least 10 d after birth. Some low level B lymphopoiesis may 
continue in the liver past this point but it is difficult to ob- 
tain clean single cell populations for analysis.  However up 
to day 10 after birth (the last point analyzed) all of the pre-B 
cells in the liver were I-A- indicating an absence of any AT 
B cell development at this site  (data not shown). 
After birth we were able to identify pre-B cells in the neo- 
natal spleen and in the peritoneal cavity. As in the liver, all 
of these were FT I-A-  pre-B cells  (Figs.  4 and 5).  In the 
PerC the pre-B cells were detectable out to 3 wk of age. In 
the spleen,  such pre-B cells were readily detectable out to 
1 mo (Fig.  4 and Table 1). Although the percentage of FT 
I-A-  pre-B  cells  decreases  over  this  time,  the  absolute 
numbers actually increase during the first month and then 
dramatically decrease. Again, the absence of any detectable 
I-A + pre-B cells indicates that both the PerC and spleen are 
sites restricted to FT B cell development during this time 
period. 
The situation in the neonatal BM is quite different. At 
day 4 after birth, essentially all of the pre-B and immature 
B cells were I-A- (Fig. 6), demonstrating the predominance 
of the FT pathway at this site. Two pieces of data indicate 
that approximately at day 4 after birth, AT B cell develop- 
ment first emerges: (a) at 8 d, I-A + (AT) pre-B cells were 
first detected in the BM (Fig. 6); and (b) 4-d FLST2 cultures 
of pro-B  cells  sorted from 4-d-old BM gave rise to both 
I-A +  (AT)  pre-B  cells  and  I-A-  (FT)  immature B  cells 
demonstrating the presence of both developmental pathways 
(Fig. 7). Thus, by 4 d although AT pre-B have not yet been 
generated, AT pro-B cells are already present. Both in vivo 
flow cytometric analysis and in vitro cultures demonstrated 
that from 4 d the BM is shifting from a site of FT to AT 
B cell development (Figs.  6 and 7).  By 3 mo of age, there 
is little evidence of any significant FT B cell development 
in the BM which is now the major site of B cell lymphopoi- 
esis for the life of the animal. 
Our studies show for the first time that the two develop- 
mental pathways are not separated during ontogeny but rather 
coexist within the animal for at least the first month of life, 
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of B cell development is the apparent compartmentalization 
of the two B cell developmental pathways. During the first 
month, when both developmental pathways are active,  we 
can find little evidence of AT B lymphopoiesis in the liver, 
spleen, or PerC although we can readily detect I-A-  (FT) 
pre-B cells. On the other hand, during this period the BM 
is dearly a site for both types of development. 
It is possible that during the first month the I-A- pre-B 
cells present in the PerC, spleens,  and livers were generated 
from pro-B cells present first in the liver and then in the BM. 
If this is true, it would mean that FT pre-B ceils are capable 
of migrating to other locations such as the spleen and PerC 
whereas the AT I-A + pre-B cells are restricted to the BM. 
The seeding of FT pre-B cells to these various locations early 
in development could be indicative of an intrinsic expansion 
program to populate specific organs with cells of this develop- 
mental lineage. While these organs lack AT pre-B cells, they 
are presumably also being flied with AT mature B cells from 
the BM during this period. 
Our results support the concept of (at least) two develop- 
mentally and functionally distinct B cell lineages within the 
immune system (10, 30-32):  one generated during fetal life 
and one in the adulthood which begins to emerge after birth. 
Developmentally, it has been shown that embryonic (33), fetal 
omentum (34), and fetal liver (9, 35) B cell progenitors pref- 
erentially give rise to B-la (CD5 +) B cells. Given our ear- 
lier studies (10) and those of Hardy and Hayakawa (9), it 
is reasonable to assume that the B-la (and possibly B-lb) lin- 
eage(s) are a part of what we have defined here as the FT 
developmental pathway. As expected, sorted I-A- pre-B cells 
from young spleens can give rise to CD5 + B ceils in FLST2 
cultures (Lain, K.-P., and A. M. Stall, manuscript in prepa- 
ration). Further studies are needed to determine whether fetal- 
derived B-la lineage is equivalent to the fetal developmental 
pathway described here or whether B-1 (a and b) cells repre- 
sent one (or more) subsets or waves of B ceils generated within 
this B cell developmental pathway. Since the in vitro stromal 
cell culture system is limited in its ability to generate and 
maintain mature B cell populations, transfer studies will be 
required to determine the total reconstructive potential of 
the I-A- pre-B calls found in neonatal spleens and the types 
of B cells to which they give rise. 
One question raised by these studies is the relationship of 
the FT B cells generated in the fetal liver to those generated 
2-4 wk after birth. Is there a single homogeneous develop- 
mental lineage throughout this period or is the FT develop- 
mental lineage itself comprised of distinct developmental sub- 
lineages? It is known that fetal liver-derived B cells have V 
gene repertoires skewed towards the D-proximal families (36) 
and with few N  region additions. Using I-A expression as 
a FT lineage marker, similar analyses of V gene usage and 
N  region additions for FT B cells generated in the spleens, 
livers,  and PerC would be possible. 
The functional significance of generating a population of 
IgM + B cells during fetal and neonatal development which 
initially lack class II expression remains to be elucidated. It 
is known that the fetal repertoire contains a high frequency 
of B cells that are low affinity,  polyreactive, and that often 
recognize self-antigens (37, 38). It is interesting to note that 
the period during which the developing fetal/neonatal IgM + 
B cells lack class II antigens corresponds exactly to the period 
when newly generated B ceils are exquisitely sensitive to toler- 
ance induction (39,  40). Altered expression of class II may 
alter the threshold of tolerance induction or donal deletion 
of these B ceils. Thus, the inability of B cells developing in 
the early immune environment to present to CD4 + T cells 
may influence the selection of such self-reactive  B cells and 
in addition, may play a role in the generation ofT-independent 
versus  T-dependent responses. 
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